MINNETONKA, Minn., June 15, 2011 /PRNewswire/ -- American
Medical Systems® (AMS) (NASDAQ: AMMD), a leading provider of
world-class devices and therapies for male and female pelvic
health, announced today the commencement of a major global registry
of penile prosthetic outcomes. The registry, entitled PROPPER
(Prospective Registry of Outcomes with Penile Prosthesis for
Erectile Restoration), is led by a team of prominent urologists
seeking to better characterize patient satisfaction associated with
modern penile prosthetic implants.
PROPPER is a large-scale observational registry expected to
enroll over 1,000 men diagnosed with erectile dysfunction (ED) for
whom an AMS penile prosthesis is recommended by their physician.
Initially, over ten sites will be involved in the research.
Patient enrollment has started and Gerard D. Henry, MD, of Regional Urology in
Shreveport, LA, was one of the
first investigators to enroll. "This registry is the first of
its kind," he explained. "I am excited about these outcome
measures that will add to the scientific literature and ultimately
allow patients and healthcare professionals to continue to make
informed choices on treatment options."
The PROPPER registry seeks to better understand real-world
outcomes for men undergoing penile implant surgery to treat
erectile dysfunction. Using questionnaires as well as
electronic data collection, investigating physicians will
prospectively measure patient responses at regular intervals over a
one- to five-year period. The physician researchers have
identified key metrics for the study including device
effectiveness, durability, complications and patient satisfaction;
quality of life will also be analyzed, being defined through
several validated patient surveys.
"American Medical Systems is pleased to be making the PROPPER
registry possible. We believe this program will play an
important role in both clinical development and physician-patient
decision making," said Whitney D.
Erickson, Senior Vice President, General Manager Men's
Health, American Medical Systems. "PROPPER demonstrates AMS'
commitment to assisting patients and healthcare professionals by
working closely with urologists to conduct objective and meaningful
research."
Results from the PROPPER registry will be published by the
researchers, with the initial outcomes expected to be made public
in 2013.
About American Medical Systems:
American Medical Systems, headquartered in Minnetonka, Minnesota, is a diversified
supplier of medical devices and procedures to cure incontinence,
erectile dysfunction, benign prostatic hyperplasia (BPH), pelvic
floor prolapse and other pelvic disorders in men and women. These
disorders can significantly diminish one's quality of life and
profoundly affect social relationships. In recent years, the number
of people seeking treatment has increased markedly as a result of
longer lives, higher quality-of-life expectations and greater
awareness of new treatment alternatives. American Medical Systems'
products reduce or eliminate the incapacitating effects of these
diseases, often through minimally invasive therapies. The company's
products were used to treat more than 340,000 patients in
2010.
More information about the company and its products can be found
at www.AmericanMedicalSystems.com and in the Company's Annual
Report on Form 10-K for 2010 and its other SEC filings.
SOURCE American Medical Systems